Promoter engineering-mediated Tuning of esterase and transaminase expression for the chemoenzymatic synthesis of sitagliptin phosphate at the kilogram-scale.
Taresh P KhobragadeSeongseon YuHyunsang JungMahesh D PatilSharad SarakAmol D PagarHyunwoo JeonSomin LeePritam GiriGeon-Hee KimSung-Su ChoSeong-Hwa ParkHye-Jung ParkHeung M KangSung R LeeMyeong S LeeJeong H KimIn S ChoiHyungdon YunPublished in: Biotechnology and bioengineering (2021)
Here, we report a bienzymatic cascade to produce β-amino acids as an intermediate for the synthesis of the leading oral antidiabetic drug, sitagliptin. A whole-cell biotransformation using recombinant Escherichia coli coexpressing a esterase and transaminase were developed, wherein the desired expression level of each enzyme was achieved by promotor engineering. The small-scale reactions (30 ml) performed under optimized conditions at varying amounts of substrate (100-300 mM) resulted in excellent conversions of 82%-95% for the desired product. Finally, a kilogram-scale enzymatic reaction (250 mM substrate, 220 L) was carried out to produce β-amino acid (229 mM). Sitagliptin phosphate was chemically synthesized from β-amino acids with 82% yield and > 99% purity.